Fasken Martineau DuMoulin LLP acted on behalf of Filament Health Corp. On July 13, 2022, Filament Health Corp (NEO:FH) closed its private placement of units and convertible...
Filament Health Corp.’s C$2.5 Million Private Placement
Filament Health Corp.’s C$12 Million IPO
Fasken acted on behalf of Filament Health Corporation in connection with its going public transaction. Filament Health Corp. (NEO: FH), a natural psychedelic drug discovery and extraction...